Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2007 Nov 28;24(11):491–505. doi: 10.1007/s10815-007-9142-9

Cytokines: Important for implantation?

Gérard Chaouat 1,, Sylvie Dubanchet 1, Nathalie Ledée 2
PMCID: PMC3455031  PMID: 18044017

Abstract

Problem

Cytokines are obviously very important in an established pregnancy, but what about human embryo implantation?

Methods

Literature review.

Results

We first discuss the necessity and limits of animal models, and then review the few cytokines which have been demonstrated by knock-out methods to be absolutely necessary for embryo implantation using in animal models. We then review what is known or discussed about the role of other cytokines as deduced from quantitative and/or qualitative dysregulation in animals and in humans.

Conclusions

Cytokines are indeed involved in implantation as they are in ongoing pregnancy and delivery. Relevance to infertility and recurrent pregnancy loss is discussed.

Keywords: Cytokines, Animal implantation, Human implantation

Introduction

One of the major achievements of reproductive immunology is that it has moved to solving an apparent [1, 2] paradox of maternal non-rejection of the ‘fetal allograft’ [3] to the discovery that the immune system was a Janus: Whereas some maternal immune system components do represent a threat to the fetus, others are useful and necessary. Classical views of the immune system as potentially deleterious to the fetal allograft implied a state of tolerance or immunosuppression. However, allogeneic embryo trophoblast, unlike allografts of paternal tissue, does not elicit rejection, perhaps because pregnancy was not inherently dangerous and did not elicit a pro-inflammatory T helper (Th)-1 type cytokine response. The discovery, by the late A E Beer and colleagues, that pre immunization of the mother to paternal alloantigens resulted in enhancement of placental weight and litter size, whereas paradoxically, animals rendered tolerant to paternal alloantigens exhibited smaller litter size and weight [4], was the first indication that an active involvement of the immune system was involved in pregnancy’s well being. These experiments were repeated and extended in a murine spontaneous abortion model derived by extension on a full CBA/J background in the original observations by DA Clark’s group [5] of a high abortion rate in CBA/J × DBA/2, but not in C3H × DBA/2 matings, and reduced abortion rates with anti-BALB/c male immunization [68] and, this time, as said Tom Wegmann, it became a matter of life for otherwise compromised fetuses, since pre immunization of the mother rescued otherwise doomed fetoplacental units and resulted in litter size and weights higher even than in controls [6, 7]. This resulted in enunciation of the “immunotrophic theory ” [9], which was quickly followed by the confirmation that indeed T cell-derived cytokines , namely IL-3 and GM-CSF, were growth factors for the trophoblast [10, 11] and were effective in preventing abortions vivo [12]. In the very same time, Jeff Pollard’s group discovered that CSF-1 was an important factor for implantation, was expressed at very high levels in the uterus, and its receptor was present on early trophectoderm and subsequently placental spongiotrophoblast [1316]. Injecting CSF-1 (M-CSF) restored macrophages but not fertility whereas mating op/op × op/+ males generated enough CSF-1 for pregnancies to succeed.

Meanwhile, we repeated [12] early experiments by Parand and Chedid [17] demonstrating that TNF-α was abortifacient, and added to the list of “bad guys” IL-2 at high doses as well as interferon-γ, and we confirmed the IL-2 data of Tezabwala et al. [20]. However, reports that (very) low doses of IL-2 plus indomethacin were abortifacient [18] were not confirmed [12, 19]. This demonstration that several inflammatory cytokines were “bad guys” was very quickly followed by enunciation by Tom Wegmann of what is now known as the “Th1/Th2 paradigm” [21, 22]. That theory was still set up in the conceptual framework of a (revised) “tolerance to the fetal allograft”. Initially envisaged as “immunosupression”, materno fetal relationship was still seen as a “depressed cellular immunity”, with a predominance of Th2 cytokines, Th1 cytokines being seen as harmful to the feto placental unit, by activating NK cells that were seen as potentially cytotoxic/cytostatic for the fetus. It became quickly apparent that this view did not apply to pre- and peri-implantation events. As early as 1992, independently but concurrently, the groups of Mc Master and Wood published that the uterus at that period was replete with inflammatory Th1-type cytokines [23, 24]. The second blow came from studies from the group of Anne Croy in 1997 stating that “Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice” [25]: NK (at least in that strain) were required for successful pregnancy! Where are we 10 years after?

Animal models?

Of mice and women

Relatively few cytokine gene knock-out mice (KOs) have shown effects on reproduction, as will be described. It is generally assumed that this reflects the existence of redundant backup circuits, and indeed from the teleological view point, it seems odd to many that such an important function as mammalian reproduction could be compromised by the deficient expression of a single cytokine. However, there are no back up circuits for a variety of hormones, so it was possible. Also, care should be taken when extrapolating murine data to human situation. As stated repeatedly by YW Loke, call “ruminations about the immune system during pregnancy...mostly centered on the acquisition of maternal tolerance to the allogeneic fetus” [2] using mice as a model have distracted us from the fact that both antigen expression by invading trophoblast as well as the anatomical relationship/invasiveness of the trophoblast creates a situation which is unique to higher primates with the possible exception of some great apes. Indeed, a disease likely linked to very early implantation defects such as preeclampsia, associated also with a “shallow invasion” of trophoblasts into maternal decidua, might indeed be observed only in humans (and some anthropologists have even expressed the concept that it might be an evolutionary difference between Neanderthals and Homo sapiens [26, 27]. However, for obvious technical reasons, we have no serial data on blood pressure during pregnancy in such species as gorillas, or orangutans. It is worth pointing out that in the mouse there is trophoblast invasion of the central artery feeding the placenta as described by Redline and Lu [28] but changes in the walls of maternal decidual arteries in mice are due to interferon (IFN)-γ rather than trophoblast invasion. The most obvious difference between human and animals is seen when dealing with pregnancy in ovine species! Here, the corpus luteum is maintained by a material, originally named trophoblastin by its inventor, sequencer, and cloner, J Martal, and rechristened oTP by the Americans, which is a bona fide new class of interferon (IFN-tau) and is therefore an absolute requirement both for successful implantation and pregnancy maintenance in the sheep, goat, and related species. It has important immunological activities, and is likely involved in establishing Th1/Th2 balance [29, 30]. However, when turning to the pig, one sees only expression of γ and δ interferons, and no oTP-like material has ever been detected in human. In the mouse, it is pituitary LH that maintains the ovary until the placenta can take over hormone production. Even though different species have developed different molecular mechanisms to achieve the same result, the objective of maintaining ovarian hormone production is the common theme.

Yet, for obvious technical and ethical reasons, we are left with no possibility to study ex vivo human uterine implantation sites. In vitro models often are “reductionist” and do not study the whole organ, so there are various possible biases introduced by cell selection during the isolation procedure, not to mention variations imposed by the culture system used. The measurements of cytokine expression in abortion tissues are always suspicious of having been modified after the induction of abortion itself, and extra-uterine pregnancies are known to differ from the physiological implantation site (e.g. by the lack of NK cells there as well as absence of spiral arteries [31, 32]). Prospective studies sampling uterine tissues post coitum and/or on the day of embryo transfer in IVF cycles are the best we can do to approach to the real situation [33, 34], and amongst several groups, the one of Sarah Robertson has excelled in that respect [35]. Thus, we are partly left with animal models, mostly rodents, because mice and rats have a hemochorial placenta which is often (wrongly) regarded as close to the human situation as one can get. But primate models are expensive, and in the case of chimps, of very limited “availability”, not to mention the rising concerns about experimentation in species closely related to humans.

The gene deficient and knockout (KO) mice

Studies in mice can be disappointing and/or misleading if not scrutinized with extreme care!

As already mentioned, CSF-1 was initially thought to be a major growth factor for trophoblasts, and CSF-1 deficient op/op mice were initially found sterile in homozygous matings, and it was then thought that implantation was deficient in the op/op mice due to lack of macrophages in the uterus [36, 37]. Then, surprisingly, op/op females mated with heterozygous males proved to be fertile, albeit at a reduced rate, and placental weights were normal, whereas systemic treatment with CSF-1 that restored macrophages failed to correct fertility. It was later on shown that the story was even more complex, since csfmop/csfmop male mice were shown to have both a reduced mating capability and too few viable sperm [38, 39]. Similarly, GM-CSF KO were first thought to have reduced implantation rate since both GM-CSF KO and GM-CSF + CSF-1 double-KO mice exhibited lower litter size than control [39, 40], but re-examination of the phenomenon showed that fetal loss was occurring by an increased resorbtion (abortion) rate post implantation [41], in agreement with the immunotrophic hypothesis and our own data on protective role of GM-CSF in a murine abortion model [12]. IL-3 KO mice also had a normal implantation rate, and IL-3/GM-CSF/IL-5βc receptor KO mice as well as IL3Rβ-deficient animals, or both, were not reported to have reproductive problems [42]. Women with pregnancy loss due to the anti-phospholipid antibody syndrome (APS) are low IL-3 producers [43] and in the CBA × DBA/2 system [12], IL-3 injection prevents abortion. In fact, a triple KO (GM-CSF + IL-3 + CSF-1) is needed to test the original immunotrophic hypothesis for abortion prevention and the role of those cytokines in implantation.

As for IL-1, Simon et al. [44] published in 1994 a headline paper in Endocrinology showing that “Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist”. However, Stewart and Cullinan [45], and then others, analyzed the reproduction of mice deficient for IL-1 and IL-1Rt1 [46] (it is an isoform of IL-1 receptor- named Il-1 receptor type 1- which is the only one which mediates transduction upon IL-1 binding). Results showed that mice lacking this receptor for IL-1 did not exhibit any significant alterations in their reproduction, apart from a slight reduction in litter size. Also no reproductive impairment was seen when Horai et al. [47] examined IL-1α/β double KO mice nor with mice deficient in IL-1α, IL-1β, or the IL-1R antagonist (IL-1ra) genes. The pups were born healthy, and their growth was normal except for IL-1ra KO mice, which showed growth retardation of pups after weaning [47, 48]. Simon himself admitted in an INSERM Philippe Laudat conference which we organized that he could not repeat 100% implantation blockade. One possible explanation (which we favor) is that the IL-1R antagonist preparation, generated in E. coli, was contaminated by minute amounts of LPS which would have induced abortifacient levels of TNF-α. Simon, however, wrote that “it should be mentioned that, although there appears to be certain evidence for the important role of the IL-1 system in murine and human reproduction” (and indeed Simon’s group has described in great detail the distribution of the IL-1 system in the human female reproductive tract) IL-1R tI−/− knockout mice, even while having smaller litter sizes when compared to wild type IL-1R tI+/+ mice, were able to reproduce.

Transgenic models are excellent tools to examine functions driven by single genes. This, however, is not the case for most reproductive functions, which are based in redundancy from the processes of implantation to parturition. Implantation is one example wherein redundant mechanisms are critical. Transgenic models therefore cannot be considered the ultimate validation of physiologic processes of reproduction that depend on redundancy for the survival of the species”. This alternative explanation is not necessarily only a “pro domo” argument: It is indeed conceivable that absence of a cytokine during early embryonic life results in the expansion of a redundant alternative pathway, and that such a development cannot take place in adult life. Nevertheless, data from Simon suggest that IL-1 is important, though not critical [4953].

However, there DO exist cytokines whose KO, or KO of their receptor, results in total implantation failure. The best known one is LIF, which was thefirst cytokine to be shown to be absolutely necessary for implantation in mice: LIF KO results in total implantation failure, and even LIF+/+ embryos do not implant in a LIF-/- mother. This can be corrected by continuous injection of recombinant LIF [54]. In humans, a certain number of sterile women have LIF deficiency as assessed by measurement of LIF production in the supernatants of endometrial explants and/or in uterine flushings [5557]. CSF-1 and IL-1 are LIF-inducers in a progesterone-prepared environment [55], and it is generally agreed (except by Hambartsoumian [58, 59] that LIF production in humans is boosted by progesterone as in animals. In the mink, where delayed implantation exists, a progesterone boost also induces LIF and subsequent implantation of “dormant” blastocysts [60]; it has been shown in a murine delayed implantation system that progesterone induces production of IL-1 and IL-6 by the previously dormant blastocysts [61]. There are LIF over producers among sterile women [6264] so not all sterility is due to LIF deficiency! Also, in our hands excess LIF and an abnormal localization are associated with failure of human implantation, not unlike a ‘too high’ CSF-1 environment which is abortifacient [65, 66], high levels of LIF might reflect (or trigger) an ongoing “chronic Th1 response” [67]. It must be mentioned that many people are aware that a well known multinational pharmaceutical company has performed in sterile women a rather large scale trial of recombinant LIF. Unfortunately, LIF was given to women without, surprisingly enough, selection of only those women displaying LIF deficiency (a small fractions of female infertilities), and thus the effect of LIF in those most likely to benefit from treatment was diluted by the result in the non LIF-deficient infertile population. It is therefore not a surprise that no significant improvement was observed in the treated group. Unfortunately this rather badly designed study impacts on the prospect of future trials being launched by other firms. Recently, in mice, LIF has been linked to the wnT beta catenin pathways and the importance of this pathway will be discussed below.

LIF is considered to be a pro-inflammatory Th1-type cytokine, and another pro-inflammatory cytokine whose defects render mice sterile is IL-11. Further, mice KO for the IL-11R receptor have impaired decidualisation leading to implantation defects [6870]. In humans, IL-11 has also been shown to play a role in decidualisation [71], and it was once thought it was acting via IL-1β. However, the IL-1β released in response to IL-11 in vitro is not the bioactive [72] isoform, so the mechanism by which IL-1β acts is still obscure, though it seems to involve the STAT3 and SOCS3 pathway [73]—and indeed, in an elegant study conducted in mice, Stat3 peptide inhibitor reduced embryo implantation) specifically by 70%[73]. Interestingly, there is a report linking IL-11 with differentiation of NK cells [74] Trophoblast cells differentiated and expressed placental lactogen-1 in IL-11Rα mice, but they did not seem to proliferate. There were marked anomalies in the decidual vasculature, and differentiated perforin-expressing uterine natural killer (NK) cells were virtually absent from implantation sites of IL-11Rα mutant mice. Direct evidence for a role of IL-11 deficiency in women with defective implantation is still lacking, albeit a decreased synthesis of IL-11 in the endometrial epithelium was noted in studies of recurrent aborters [71, 74], and reduced levels of endometrial IL-11 (and LIF) was noted in women suffering implantation defects as well as when women who were compared to fertile women were selected as infertile with endometriosis [7577]. These data are consistent with data suggesting that natural cycles may be better for implantation, and reduced expression of IL-11 and IL-6 occurs in the peri-implantation endometrium of excessive ovarian responders [78, 79].

Il-15

IL-15 is expressed in the reproductive tract [80], and is a growth factor for uterine NK cells in mice and human [81, 82], and it also activates the cells to display high levels of granzyme and perforin [83]. In a series of elegant experiments, using recombination-activating gene (Rag) 2/common cytokine receptor γ chain deficient mice, (Rag2−/−γc−/−) Barber and Pollard demonstrated that uNK cells likely originate from the bone marrow and require IL-15 to develop in the uterus [84]. Surprisingly, those mice proved rather resistant to Listeria monocytogenes infection. The most important finding in this series of experiments was that IL-15 KO mice lacked uterine NK cells but did not show implantation or peri-implantation defects nor fetal resorptions, in contrast to the results of Guimond et al. [131] using the TgE26 mouse. The embryonic problems in the TgE26 mouse may be due to loss of the T cells, or perhaps an altered intestinal flora (as LPS is known to cause both implantation failure and resorptions). However, in agreement with the Croy group studies, the loss of uNK cells in IL-15 KO mice did result in failure to remodel (thin) the maternal arterial walls and there was a hypocellular decidua basalis. These defects in uNK-deficient Rag2−/− γc−/− mice were correctable by bone marrow transplantation that restored the uNK cell population [84]. In humans, elevated IL-15 [34, 85] (and, surprisingly, in one study, the “Th2 like” IL-13 [85]) have been associated implantation failure and recurrent spontaneous abortions (see Table 1). IL-15 levels, as other cytokines, seem to be controlled by sHLA-G [86].

Table 1.

Selected cytokines in implantation versus post-implantation events

Cytokine Implantation Post-implantation (abortion/resorption)
Success Failure Success Failure
IL-1 Ab neut (?) Helps
IL-2 High doses cause High doses cause
IL-3 High doses help High doses prevent
IL-4 High doses help
IL-5 No effect No effect
IL-6 High doses cause (?) High doses (?)
IL-8 ND ND
IL-10 No effect Helps in resorb prone strains
IL-11 KO causes
IL-12 High doses cause High doses cause
IL-13 Causes (?)
IL-15 KO no effect except arteries KO no effect except arteries
IL-18 High doses cause High doses cause
IL-23 High doses cause ND
IL-27 High doses cause High doses cause
LIF KO causes
CSF-1 KO causes
GM-CSF KO no effect Prevents KO increases
TNF-α High doses cause High doses cause
IFN-γ KO no effect High doses cause
TGF-α Required for adhesion ND
TGF-βs Prevents KO may cause (?)

IL-6

IL-6-deficient mice have yielded conflicting results: For Poli, homozygous males and females are fertile [87] but for Robertson, these mice have a decreased litter size associated with fewer implantation sites compared to controls [88]. Zenclussen et al. [89] found elevated serum IL-6 levels in a murine abortion-prone mating combination, but Robertson’s group found a reduced expression of IL-6 and IL-1α mRNAs in secretory phase endometrium of women with recurrent miscarriage [35].

IL-5

Robertson reported that implantation rates and subsequent fetal development were comparable in IL-5−/− and IL-5+/+ C57BL/6 mice, irrespective of whether pregnancies were sired by syngeneic (C57Bl/6) or allogeneic (CBA or BALB/c) males. There was a 10% increase in placental size and a 6.5% decrease in placental/fetal ratio seen on day 17.5 in pregnancies sired by CBA males [90].

Transforming growth factors (TGFs)

TGF-βs are well known to be immunosuppressive and also to act on the LIF/IL-6 pathway [91, 92], enhancing the former and decreasing the later for in vitro cultured endometrial cells, including in the human. In mice, besides immunosuppressive properties, TGF-α promotes mouse blastocyst outgrowth and secretion of matrix metalloproteinases. TGF-β1—and mildly TGF-β2 or TGF-β3—also stimulates mouse blastocyst outgrowth [9395]. Other results in rats also suggest that under hormonal regulation TGF-βs repress sialomucin and thus the sialomucin complex (SMC/Muc4), SMC being an anti-adhesive glycoprotein, and thus permitting implantation [96]. Therefore, TGFs are likely very important in implantation. However, KOs studies are seriously hampered by the fact that 50% of TGF-β1−/− embryos die in the uterus and the other 50% early after birth, before reproductive age [97], and thus it is often concluded that the studies did not yield conclusive results. However, using a human TGF-α transgenic mouse, it has been shown that its inappropriate expression down-regulates uterine expression of TGF-β receptor subtypes and delays the attachment reaction with deferred uterine expression of amphiregulin [98]. I will not detail here the well-known effects of the TGF-β2 isoform in pregnancy and invite the readers to refer to [99101].

WnT

Recently, very elegant studies by the group of Dufort et al. [102] have that activation of the Wnt/β-catenin signaling pathway is required for implantation, and this depends on soluble embryonic factors; The Wnt/β-catenin involvement occurs at two different stages. Implantation first requires a transient activation in circular smooth muscle on early day 4. Subsequently, activation is restricted to the luminal epithelium at the prospective site of implantation. Subsequent experiments have shown that the pathway is involved in LIF regulation.

Tumour necrosis factors (TNF)

TNF-α is markedly over expressed in the pre- and peri-implantation uterus, in marked contrast with its limited expression during established pregnancy [23, 24]. It is generally assumed from a lot of studies as early as the ones of Parand and Chedid [17] and ours [12] that excess local TNF-α also reduces litter size or prevents implantation in mice, rats, and humans [103]. For cattle, refer to [104106]. One should note that of course in contrast to animal studies, human effects are deduced from correlative studies on serum and local TNF-α levels in sterilities/RSA women and no direct injection of TNF-α, nor LPS, nor a TNF-α inducer, has been ever attempted! But there have been studies in primates with neem extract, a Th1 cytokine inducer [107] However, TNF-α (as well as LIF, TGF-β, IL-1, IL-6 and insulin-like growth factor binding protein-1 (IGFBP-1) markedly influence the secretion and/or activation of MMP-2 and MMP-9 according to Bischof [108, 109], thus promoting early and late trophoblast invasion. One possible explanation would be that several effects of TNF-α are prevented in early implantation by tweak [110] as in other systems [111]. However, TNF-α KO mice have perfectly normal implantation rates so TNF-α is not required for normal implantation [112].

Th2 cytokines

It is noteworthy that all the KOs described above, which are amongst the (few) where implantation defects have been detected, concern pro-inflammatory Th-1 cytokines. In the CBAxDBA/2 murine abortion model where there is a pro-inflammatory cytokine response, and an IL-10, IL-3 and IL-4 defect, and anti-IL-10 enhanced resorbtion rates. However, there was no effect of anti-IL-10 in other, non abortion-prone murine mating combinations [113]. The first IL-10 KO mice had no fertility problem, and that was confirmed with single and multiple Th2 cytokine KOs, including a quadruple Th2 cytokine KO (but with normal IL-3 production) [114117]. In humans, there is evidence from a variety of studies that Th2 cytokines defects in production/ and/or expression are associated with early pregnancy loss see [103]—albeit the very existence of a Th2 bias has been debated [118]. But there is no convincing data as far asimplantation itself is related to Th2 cytokine deficiencies. The Th2 like cytokine, IL-13, is present as a “Th2” shield all around the peri-implantation embryo [81] but its KO does not affect implantation [115]. Excess IL-13, is associated with RSA [85], but there is no evidence for implantation problems.

Altogether, the KO mouse data did not seem to support a major role of Th2 cytokines in implantation, but rather point out that several pro-inflammatory Th1 and Th1-like cytokines are important, the presence of some of them being an absolute requirement . However, an important point to add is that for most of these KO, or antibody mediated cytokine neutralization, the deduction that a cytokine is not required for successful pregnancy stems from studies conducted in the KO strain itself, e.g. with congenic matings, which means syngeneic pregnancies where there are no paternal allloantigens. Further comments on this issue are provided at the end of this essay.

Cytokines in the semen

The uterus seems to be prepared for implantation by cellular and cytokine constituents in seminal fluid, and indeed a human endometrial cellular response comparable to what is observed after mating in mice have been reported [110]. The cellular influx, and most important, surge in local production of proinflammatory cytokines observed after mating in mice is not seen when females are mated with vasectomised mice which deliver no seminal fluid. Elegant studies by Robertson’s group imply seminal TGF-β (which induces production of GM-CSF) as pivotal to such preparation of the uterus, and possibly promoting maternal immunological tolerance to paternal antigens, a phenomenon which may be important in preventing preeclampsia as described by Robillard et al. [27, 28]. The reader is referred to their excellent reviews on that topic [119, 120].

The role of the immune system on local vascularization

An embryo can implant but cannot develop without an increased blood supply form the mother. An “angiogenic” role of NK cells was predicted by Loke in 1991 [122] when he wrote that uterine NK cells “may have a role in the control of implantation and the transformation of the uterine vasculature by trophoblast on which the blood supply to the fetoplacental unit depends”. In fact, there was already more and more data showing that the implantation uterus stroma was full of NK cells (up to 60 to 80% of the “ stroma” in mice and human, which is more lymphocytes than are present in some lymph nodes) [123129]. For years, NK cells were seen as “bad guys”in the context of the classical Th1/Th2 paradigm, and their “activation” towards a cytostatic/cytotoxic pathway by Th1 cytokines was believed to lead to pregnancy failure, albeit there were relatively few indications in animal models (except for activation by poly I: C) that activated NK cells could affect implantation itself (rather than causing early pregnancy loss as in the CBA × DBA/2 model [121]). NK-lineage cells infiltrating the uterus were activated as early as day 6.5 to massively secrete IL-18 (a cytokine that promotes secretion of IFN-γ), and there was more IL-18, in the non abortion prone mating with BALB/c than in the abortion prone one with DBA/2 [129]. Yet, IL-18, alone, or with IL-12, is abortifacient in established pregnancy, and has been implied to play a role in a murine preeclampsia model, as first reported by a Japanese group [130]. The role of uterine NK (uNK) cells was further elucidated by Guimond et al. [25, 128, 131]: NK deficient TgE26 mice (which also have a T cell defect) had profound reproductive defect with reduced placental size and lack of transformation of the uterine arteries which retained too thick arterial walls, a feature ultimately leading to a high percentage of fetal deaths. As previously mentioned, thick vascular walls, absence of transformation also occurred in IL-15 KO mice, and fetal weight was reduced, but there was no fetal lethality. However, implantation was not affected in any of these NK deficient mice. Subsequent experiments proved that IFN-γ was a key activator of NK cells and as a product of NK cells, caused vascular wall remodeling directly altering arterial wall thickness in NK-deficient pregnant mice [132136]. IFN-γR KO mice also have vascular wall anomalies. Uterine NK cells secrete several angiogenic factors, including angiopoietin 2 and VEGF [134140]. It should be recalled here that high doses of IFN-γ can prevent implantation in mice and an “immunodystrophic hypothesis” stems from correlative studies in human [142144]. Such high doses of IFN-γ are also abortifacient during “established pregnancy”, synergising with TNF-α and having a procoagulant induction effect [reviewed in 103]. But, at lower doses, IFN-γ is involved in promoting a beneficial placental phagocytic activity [145]. IFN-γ and IL-15 activate pre-/peri-implantation murine uNK cells, and at the relatively low doses which arise post-coïtum when T cells and macrophage move in to dispose of those spermatozoa and lymphocytes which die in situ.

As far as VEGF is concerned, it is expressed in the pre- and peri-implantation uterine stroma proper, in addition to uNK cells, in human and animals [141, 146151], including in species with delayed implantation such as the mink [152]. In some species, VEGF is expressed in placentomes [153]. VEGF is partly regulated by hormones during the cycle as well as chorionic gonadotropin at implantation and [146, 147, 153157]. Indeed mefipristone down-regulates local VEGF production [158], whereas, conversely, HLA-G (a non polymorphic Class I HLA antigen present on extravillous human trophoblasts), while inhibiting NK cell mediated cytotoxicity [2, 122, 159161], up-regulates VEGF production by uNK cells [162], a property fitting with a role of HLA-G in angiogenesis [163]. These observations have led to studies showing prevention of implantation in rhesus monkeys by injecting neutralizing antibody to VEGF-A “apparently through direct antagonism of the action of VEGF-A in the endometrium” [164]. In addition to VEGF, there are also soluble angiopoietins now described.

Angiopoietin-2 (Ang-2) is secreted mostly by uNK cells, in mice and human, rather than uterine stroma [136140, 146, 164166]. In fact, in mice Ang-2 mRNA and protein expression is seen in uterus in both the estrogen-dominated cycling phase and the progesterone-dominated mated phase, whereas Ang-1 expression was restricted to the mated phase .However, Ang-1 is also expressed by pre-implantation mouse embryos and may act as a possible complement to expression of mouse uterine: Angiopoietin-1 mRNA was found to be expressed throughout development in 78% of zygotes, 66% of 2-cell-embryos, 71% of 4-cell-embryos, 70% of 8-cell-embryos, 60% of morula stage embryos, 48% of early blastocysts, and 78% of late blastocysts. The number of Ang-1-expressing embryos in the early-blastocyst group was significantly different in comparison with zygotes, 4-cell-embryos, 8-cell-embryos and late blastocysts. However, Ang-2 mRNA and protein expression could not be detected in pre-implantation embryos [165].

Robertson et al. have shown that GM-CSF induced by TGF-β promotes implantation and can stimulate metabolism and development of pre-implantation embryos. GM-CSF is also a product of uNK cells [159]

Quantitative local dysregulations

The total (systemic + local) absence of a cytokine is in fact unlikely to be observed in human for the first time at reproductive age. For example, the aforementioned murine LIF−/− embryos give rise to mice which have subnormal levels of ACTH, absent nerve repair after injury, defective neural stem cell renewal in the adult brain, postnatal maintenance of distal axons and motor endplates. LIF plays a protective role in endotoxic shock and host defense, and with IGF-1 facilitates lung maturation, etc. It is thus very unlikely that women with global LIF deregulation would reach reproductive age without being affected by several other LIF deficiency-related pathologies. In infertile women LIF deficiency was diagnosed by examination of local LIF production, be it by flushing, immunohistochemistry or quantification in explant culture supernatants or by RTPCR for mRNA [5557]. So, local dysregulation which affect only either the uterine part of the feto maternal interface or are affecting the embryo itself in an autocrine fashion are likely most important. A further example is the local production of IL-12, and IL-18 [33, 35, 83]. The local absence of those cytokines in a pre implantation uterus in our hands is associated with a very low number of NK cells, and as a correlate, low production of angiogenic cytokines, as is also the case in low IL-15 producers. It is interesting to note that in several of those women a more global lack of production of implantation related cytokines by the cycling uterus is demonstrable. A possible explanation would be a defect in an important upstream signaling pathway, such as Wnt, or such genes as homeobox HOX-7.1T/Msx 1. It is hoped that Microarray studies will eventually identify such upstream regulators. Alternatively, there may be an abnormal response to the IVF stimulation protocol. Ledée-Bataille et al. [78] have suggested this by comparing IVF in natural cycles to cycles where oocyte production was induced, coming to the conclusion that “Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count”. This is further supported by the aforementioned studies showing that a reduced expression of IL-11 and IL-6 in peri-implantation endometrium is observed in excessive responders to ovulation induction [79], and may account for lower implantation rates.

It is interesting also to note in that context that reduced endometrial IL-11 and/or LIF may also contribute to infertility in some women with endometriosis and/or recurrent miscarriages. Defective production of LIF, CSF-1 (M-CSF) and Th2-type cytokines by T cells at fetomaternal interface is also associated with pregnancy loss [167169]. In line with the initial assessment of infertility in op/op mice, the number of uNK cells as well as the number of uterine leucocytes expressing CSF-1 and c-fms mRNAs was substantially lower in the uteroplacental unit of mice with pregnancy loss than in control animals [170].

In addition, in mice and humans, IL-18s regulated by EBI3 or IL-18 BP (IL-18 binding protein). In humans, abnormal regulation correlates with a pathologic sub-endometrial vascular flow index (VFI), and IL-15 levels correlate with high IL-18 levels in sterile patients, but not completely with excess NK counts so that the main effects are likely NK cytotoxic activation rather than replication which seems more strongly correlated to the ratio IL-18/IL-18 BP [33, 34]. Experimentally, as stated above injection of high doses of IL-12 or IL-18, or both, produce abortion and /or a pre eclampsia like syndrome in mice [130, 171, 172].

Many other examples of implantation defects linked with too high a production of cytokines or abnormal localization exist! Too high levels of LIF in the luminal fluid are predictive of a poor IVF-ET outcome, and this might reflect as stated above a “chronic Th1-like hyperactivation” [67], as are poor prognosis patients with detectable levels of IL-18 in luminal fluid [173]. Similarly, too early too high levels of CSF1 are abortifacient: Pre-immunizing B6 mice with a syngeneic tumors that regressed due to an effective host anti-tumor response also prevented normal gestations when the tumor-immunized mice were mated to C57BL/6J × DBA/2 F-1 (B6D2F1) males or DBA/2 males but sustain normal pregnancies when impregnated by CBA/J or C57BL/6 males. Thus, as in other murine abortion systems, susceptibility to embryo rejection was highly strain dependent. An investigation into the cause of these male-specific pregnancy failures led Tartakowsky to propose that CSF-1 was responsible for both pregnancy-block and resorption of embryos. Indeed, injection of very small amounts of CSF-1 into mated (plugged) females, during the first 5 days of pregnancy, was sufficient to block B6xB6D2F1 gestations but had no effect on B6xCBA/J matings [174, 175]. Too high levels of TNF-α? as a consequence of infection, or direct injection, or with very high doses of Poly IC, also prevent implantation and/or induce abortions [103]. The effect observed on abortion rates is not mediated primarily by cytostatic/cytotoxic effects on embryo, but rather by action on the coagulation pathway, and this can be prevented by anti-FGL2 prothrombinase [176]. These studies paved the way for those implying CD200/CD200R in prevention of abortion pregnancy loss [101]. Studies conducted at low doses of Poly IC which do not affect the number of implantation sites show that it also induces early post implantation impairment of uterine vascular remodeling in CBAxDBA/2 mice [103, 121]. Cytokines influencing Th1 and Th2 cell differentiation, including IFN-γ, IL-2, IL-4, IL-5, IL-10 and IL-12p40, as well as dendritic cell-regulating cytokines IL-1α, IL-1β, IL-6, LIF, GM-CSF and TNF-α were also expressed similarly regardless of fertility status. This is, incidentally, in marked contrast with data on such cytokines claimed in some murine studies, where some labs claiming the surprising “complete prevention of abortion” in a murine model of spontaneous abortion (e.g. well below the well known irreducible “genetic background” linked to chromosome anomalies).

TNF-α is also implicated in the pathways mediating stress related implantation failure or early pregnancy loss: for review see [177, 178]. However, it should be noted that ‘occult’ loss observed, for example, in C57BL/6 mice, which is in fact an implantation failure, did not require TNF-αR1 [179, 180].

In lines with those data and other linking excess Th1 cytokines and early pregnancy loss abortion, excess expression of IL-23 [110, 181] or IL-27 is/seem abortifacient [110] but, as stated above and paradoxically, excess Th2 like cytokine IL-13 seems to be involved in some abortions [85], though this is not corroborated by two more recent studies, which, however, do not check endometrium but serum levels [182, 183].

IL-6 data are contradictory. IL-6 was found to be elevated in abortion prone mice by Zenclussen et al. [89], found elevated in human MPLR by the Raghupathy group [184], but most other studies have not found such a correlation with either abortion or early implantation failure—see for brief review [39].

Reports on local production of TGF-β and implantation are contradictory: Most of them find an association between TGF-β deficiency and implantation failure /recurrent pregnancy loss, but there are nonetheless reports that do not find such correlation [39]. Most have studied TGF-β1, but there are other isoforms that can have specific effects. TGF-β2-like factors are implicated in abortions in mice and in humans, whereas inhibition of trophoblast growth by TGF-β3 has been implicated in pre-eclampsia [185, 186].

Immunoregulatory T cells

Foxp3+ regulatory T cells Treg cells) have been implicated in prevention of early pregnancy loss and abortion in allogeneic matings in mice [187, 188]. A similar role is purported in human [189191]. For example, in a human study, foxp3 mRNA was reduced 2 fold in the uteri of infertile women, but although Treg cell differentiation is controlled by TGF beta, the relative abundance in endometrial tissue of TGF-β1, TGF-β2, TGF-β3 mRNAs was not changed in infertile women. Treg cells can act directly to suppress or by inducing cytokine-releasing Tr1 cells (which produce IL-10) or Th3 cells (with produce TGF-β).

Some additional mechanisms of action

Besides embryo growth promotion, from the uterus to the embryo, cytokines are involved in the induction/regulation of MMP/TIMPs which are important for implantation [108, 109, 192195], as well as integrins integrin receptors [192, 196200]. Cytokines are also produced by embryo itself, and for example as quoted Il-1 and IL-6 are produced upon maternal hormone activation of otherwise dormant embryos [61]. Recent afore quoted studies on Wnt further support the concept of embryo signals acting on the uterus [102]. However, results on cytokine detection in embryo culture supernatants and IVF success have so far failed to yield conclusive reproducible results, and thus, we will not detail them here Finally, cytokines might act before Implantation and act on the embryo itself. Of considerable interest in this context seem to us earlier data of Tartakovsky’s group who obtained almost complete prevention of abortion in a variation (embryo transfer) of the classical CBA × DBA/2 murine model of spontaneous abortion by pre culturing embryos of resorbing mating combination in CSF-1 before embryo transfer. Similar epigenetic determinants (and let us recall that there is imprinting in the CBA × DBA/2 system [201]—though implantation and abortion were not recorded) were reported when in another embryo transfer system embryos were cultured in GM-CSF [201, 202].

As we discuss elsewhere [110] this is in keeping with the data of Girardi et al. [204] showing that the embryo resorption process is heralded very prior to implantation by complement activation. However, resorptions can be stopped by treatment much later in pregnancy, including by administering anti-asialoGM1, CD200Fc, by hirudin (a direct anti-thrombin), by anti-neutrophil antibody, or by anti-FGL2 prothrombinase. The immune system can activate the complement system, and C5a activates neutrophils that are recruited by cytokines released by thrombin-activated endothelial cells. Therefore the coagulation system and complement system may collaborate in the abortion process.

Conclusion

The data reviewed here establish that cytokines are important for implantation. In keeping with other data, pro-inflammatory Th1-type cytokines appear from KO mouse studies to be key determinants of attachment and adhesion stages of implantation but later on, also regulate integrins, TIMP/MMP balance, etc. In contrast, KO mice have NOT demonstrated a mandatory requirement for Th2 cytokines in the process. Proper NK cell “activation”, not “dampening”, is required for optimal local vascular bed transformation. In keeping with the Th1/Th2 paradigm, excess peri-implantation Th1 cytokines may induce early pregnancy loss/abortion. However, a growing body of evidence suggests the importance of NK controlled angiogenic network, and for example VEGF/sVEGFR/NK cells might be important in implantation related/initiated diseases such as pre eclampsia. However, careful examination of the networks suggests several distinct pathway of cytokine/cytokine dysregulation related implantation failure. These data point to tailored therapies, some as simple as natural vs. stimulated cycle, some involving tailored drug administration. As presented recently by Ledée, we believe the time has come, but also that such an era is just beginning!

An important point to add is that for most of these KO, or antibody mediated cytokine neutralization, the deduction that a cytokine is not required for successful pregnancy stems from studies conducted in the KO strain itself, e.g. with congenic matings, which means syngeneic pregnancies. Tregs are required for successful allopregnancy to proceed, but Treg depletion has no effect in syngeneic pregnancy [187]. Similarly, IDO neutralization has (quantitatively) strain dependent abortifacient effects only in allogeneic matings [180, 205]. Except for the effects of anti IL-10, which one of the authors has studied in a series of allogeneic pregnancies [113], it is not sure that allogeneic pregnancies would not be compromised by the KO, since the proper studies have not been conducted. It is easy to understand why (a) most of the workers likely did not even think of it (b) would have they done so, the fact that this would require two allogeneically disparate murine strains was certainly a powerful deterrent. As a typical example, as stated above and [206], T regs are implied as important for allo pregnancy, even though Wasp−/− mice have impaired T reg function [207209], but these syngeneically bred mice have no noticeable reproductive defects. Notably, they have not a high resorption rate nor do they have smaller implantation rates and/or litter size (Snapper; Dupre; Roncarolo; Rawlings; personal communications).

References

  • 1.Anderson CC, Matzinger P. Danger: the view from the bottom of the cliff. Semin Immunol. 2000;12:159–162. doi: 10.1006/smim.2000.0236. [DOI] [PubMed] [Google Scholar]
  • 2.Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6:584–594. doi: 10.1038/nri1897. [DOI] [PubMed] [Google Scholar]
  • 3.Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;7:320–338. [Google Scholar]
  • 4.Beer AE, Scott JR, Billigham RE. Histoincompatibility and maternal immunological status as determinants of fetoplacental weight and litter size in rodents. J Exp Med. 1975;142:180–196. doi: 10.1084/jem.142.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chaouat G, Kiger N, Wegmann TG. Vaccination against spontaneous abortion in mice. J Reprod Immunol. 1983;8:389–394. doi: 10.1016/0165-0378(83)90248-6. [DOI] [PubMed] [Google Scholar]
  • 6.Clark DA, McDermott MR, Szewczuk MR. Impairment of host-versus-graft reaction in pregnant mice. II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy. Cell Immunol. 1980;52:106–118. [PubMed] [Google Scholar]
  • 7.Chaouat G, Kolb JP, Kiger N, Stanislawski M, Wegmann TG. Immunological concomitants of vaccination against abortion in mice. J Immunol. 1985;134:1594–1598. [PubMed] [Google Scholar]
  • 8.Chaouat G, Kiger N, Chaouat G, Kolb JP, Wegmann TG, Guenet JL. Immunogenetic studies of spontaneous abortion in mice. I Preimmunisation of the mother with allogeneic spleen cells. J Immunol. 1985;134:2966–2972. [PubMed] [Google Scholar]
  • 9.Wegmann TG. Fetal protection against abortion: is it immuno suppression or immuno stimulation? Ann Immunol Inst Pasteur. 1984;135D:309–311. doi: 10.1016/s0769-2625(84)81196-4. [DOI] [PubMed] [Google Scholar]
  • 10.Athanassakis I, Bleackley RC, Paetkau V, Guilbert LL, Barrp J, Wegmann TG. The immunostimulatory effects of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol. 1987;138:37–44. [PubMed] [Google Scholar]
  • 11.Armstrong DT, Chaouat G. Effects of lymphokines and immune complexes on murine placental cell growth in vitro. Biol Reprod. 1989;40:466–475. doi: 10.1095/biolreprod40.3.466. [DOI] [PubMed] [Google Scholar]
  • 12.Chaouat G, Menu E, Dy M, Minkowski M, Clark DA, Wegmann TG. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil. 1990;89:447–458. doi: 10.1530/jrf.0.0890447. [DOI] [PubMed] [Google Scholar]
  • 13.Bartocci A, Pollard JW, Stanley ER. Regulation of colony stimulating factor 1 during pregnancy. J Exp Med. 1986;164:956–961. doi: 10.1084/jem.164.3.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, Pollard JW. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab. 1992;74:850–858. doi: 10.1210/jcem.74.4.1548350. [DOI] [PubMed] [Google Scholar]
  • 15.Arceci B, Shanahan F, Stanley ER, Pollard JW. The temporal expression and localization of colony stimulating factor (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1 regulated placental development. Proc Natl Acad Sci USA. 1989;86:8811–8818. doi: 10.1073/pnas.86.22.8818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pollard JW. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Dev. 1997;46:54–61. doi: 10.1002/(SICI)1098-2795(199701)46:1<54::AID-MRD9>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  • 17.Parand M, Chedid L. Protective effects of chlorpromazine against endotoxin induced abortion. Proc Soc Exp Biol Med. 1964;116:906–915. doi: 10.3181/00379727-116-29404. [DOI] [PubMed] [Google Scholar]
  • 18.Lala PK, Scodras JM, Graham CH, Lysiak JJ, Parhar RS. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise. Cell Immunol. 1990;127:368–381. doi: 10.1016/0008-8749(90)90139-i. [DOI] [PubMed] [Google Scholar]
  • 19.Clark DA, Chaouat G, Kennedy T, Banwatt D, Ross E. Effect of prostaglandin synthesis on spontaneous and endotoxin induced abortion in mice. J Reprod Immunol. 1993;24:29–45. doi: 10.1016/0165-0378(93)90034-f. [DOI] [PubMed] [Google Scholar]
  • 20.Tezabwala BU, Johnson PM, Rees RC. Inhibition of pregnancy viability in mice following IL-2 administration. Immunology. 1989;67:115–119. [PMC free article] [PubMed] [Google Scholar]
  • 21.Wegmann T, Lin H, Guilbert L, Mossman TH. Bidirectional cytokines interactions in the materno fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol Today. 1993;14:353–355. doi: 10.1016/0167-5699(93)90235-D. [DOI] [PubMed] [Google Scholar]
  • 22.Lin H, Mossmann TR, Guibert L, Tuntipopat S, Wegmann TG. Synthesis of T helper-2 cytokines at the maternal fetal interface. J Immunol. 1993;151:4562–4573. [PubMed] [Google Scholar]
  • 23.Mac Master MT, Newton RC, Dey SK, Andrews GK. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol. 1992;148:1699–1705. [PubMed] [Google Scholar]
  • 24.Sanford T, De M, Wood G. Expression of colony stimulating factors and inflammatory cytokines in the uterus if CD1 mice during days 1 to days 3 of pregnancy. J Reprod Fertil. 1992;94:213–220. doi: 10.1530/jrf.0.0940213. [DOI] [PubMed] [Google Scholar]
  • 25.Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA. Abscence of Natural Killer cells during Murine pregnancy is associated with Reproductive compromise in TgE26 mice. Biol Reprod. 1997;56:169–179. doi: 10.1095/biolreprod56.1.169. [DOI] [PubMed] [Google Scholar]
  • 26.Chaline J. Increased cranial capacity in hominid evolution and preeclampsia. J Reprod Immunol. 2003;59:137–152. doi: 10.1016/s0165-0378(03)00043-3. [DOI] [PubMed] [Google Scholar]
  • 27.Robillard PY, Dekker G, Chaouat G, Hulsey TC. Etiology of preeclampsia: maternal vascular predisposition and couple disease-mutual exclusion or complementarity? J Reprod Immunol 2007 Dec; 76(1–2): 1–7. Epub 2007 Nov 7. [DOI] [PubMed]
  • 28.Redline RW, Lu CY. Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal–fetal immunological relationship. Lab Invest. 1989;61:27–36. [PubMed] [Google Scholar]
  • 29.Martal TL, Chene NM, Huynh LP, L’Haridon RM, Reinaud PB, Guillomot MW, et al. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure–function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie. 1998;80:755–777. doi: 10.1016/s0300-9084(99)80029-7. [DOI] [PubMed] [Google Scholar]
  • 30.Bazer FW, Spencer TE, Ott TL. Interferons tau: a novel pregnancy recognition signal. Am J Reprod Immunol. 1997;37:412–421. doi: 10.1111/j.1600-0897.1997.tb00253.x. [DOI] [PubMed] [Google Scholar]
  • 31.Proll J, Bensussan A, Goffin F, Foidart JM, Berrebi A, LeBouteiller P. Tubal versus uterine placentation: similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens. 2000;56:479–491. doi: 10.1034/j.1399-0039.2000.560601.x. [DOI] [PubMed] [Google Scholar]
  • 32.Ordi J, Casals G, Ferrer B, Creus M, Guix C, Palacin A, et al. Uterine (CD56+) natural killer cells recruitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol. 2006;55:369–377. doi: 10.1111/j.1600-0897.2006.00377.x. [DOI] [PubMed] [Google Scholar]
  • 33.Ledee-Bataille N, Dubanchet S, Coulomb-L’hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril. 2004;81:59–65. doi: 10.1016/j.fertnstert.2003.06.007. [DOI] [PubMed] [Google Scholar]
  • 34.Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization–embryo transfer failure. Fertil Steril. 2005;83:598–605. doi: 10.1016/j.fertnstert.2004.11.021. [DOI] [PubMed] [Google Scholar]
  • 35.Jasper MJ, Tremellen KP, Robertson SA. Reduced expression of IL-6 and IL-1α mRNAs in secretory phase endometrium of women with recurrent miscarriage. J Reprod Immunol. 2007;73:74–84. doi: 10.1016/j.jri.2006.06.003. [DOI] [PubMed] [Google Scholar]
  • 36.Arceci B, Shanahan F, Stanley ER, Pollard JW. The temporal expression and localisation of colony stimulating factor (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1 regulated placental development. Proc Natl Acad Sci USA. 1989;86:8811–8818. doi: 10.1073/pnas.86.22.8818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pollard JW, Hunt JW, Wiktor Jedrzejczack W, Stanley ER. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol. 1991;148:273–283. doi: 10.1016/0012-1606(91)90336-2. [DOI] [PubMed] [Google Scholar]
  • 38.Cohen PE, Chisholm O, Arceci RJ, Stanley ER, Pollard JW. Absence of CSF1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod. 1996;55:310–317. doi: 10.1095/biolreprod55.2.310. [DOI] [PubMed] [Google Scholar]
  • 39.Makrigiannakis A, Minas V, Kalantaridou SN, Nikas G, Chrousos GP. Hormonal and cytokine regulation of early implantation. Trends Endocrinol Metab. 2006;17:178–185. doi: 10.1016/j.tem.2006.05.001. [DOI] [PubMed] [Google Scholar]
  • 40.Seymour JF, Lieschke GJ, Grail D, Quilici C, Hodgson G, Dunn AR. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood. 1997;90:3037–3049. [PubMed] [Google Scholar]
  • 41.Robertson SA, Roberts CT, Farr KL, Dunn AR, Seamark RF. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol Reprod. 1999;60:251–261. doi: 10.1095/biolreprod60.2.251. [DOI] [PubMed] [Google Scholar]
  • 42.Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T, et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while β IL3 receptor-deficient mice are normal. Immunity. 1995;2:211–222. doi: 10.1016/1074-7613(95)90046-2. [DOI] [PubMed] [Google Scholar]
  • 43.Shoenfeld Y, Sherer Y, Fishman P. Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol Suppl. 1998;107:19–22. doi: 10.1080/03009742.1998.11720701. [DOI] [PubMed] [Google Scholar]
  • 44.Simon C, Frances A, Piquette GN, Danasouri IE, Zurawski G, Dang W, et al. IL-1 receptor antagonist prevents successful implantation in mice. Endocrinology. 1994;134:521. doi: 10.1210/endo.134.2.8299552. [DOI] [PubMed] [Google Scholar]
  • 45.Stewart CL, Cullinan EB. Preimplantation development of the mammalian embryo and its regulation by growth factors. Dev Genet. 1997;21:91–101. doi: 10.1002/(SICI)1520-6408(1997)21:1<91::AID-DVG11>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  • 46.Abbondanzo SJ, Cullinan EB, McIntyre K, Labow MA, Stewart CL. Reproduction in mice lacking a functional type 1 IL-1 receptor. Endocrinology. 1996;137:3598–3601. doi: 10.1210/endo.137.8.8754793. [DOI] [PubMed] [Google Scholar]
  • 47.Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med. 1998;187:1463–1475. doi: 10.1084/jem.187.9.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Horai R. IL-1 receptor antagonist knockout mice. Nippon Rinsho. 2005;63(Suppl 1):55–58. [PubMed] [Google Scholar]
  • 49.Simon C, Piquette GN, Frances A, Polan ML. Localisation of interleukin 1 type 12 receptor and interleukin 1β in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab. 1993;77:594–595. doi: 10.1210/jcem.77.2.8345061. [DOI] [PubMed] [Google Scholar]
  • 50.Simon C, Frances A, Piquette GN, Zurawsky G, Deng W, Polan ML. Interleukin 1 system in the maternotrophoblast unit in human implantation. Immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab. 1994;878:847–854. doi: 10.1210/jcem.78.4.8157710. [DOI] [PubMed] [Google Scholar]
  • 51.Santos MJ, Mercader A, Frances A, Portoles E, Remohi J, Pellicer A, et al. Role of endometrial factors in regulating secretion of components of the human embryonic interleukin 1 system during embryonic development. Biol Reprod. 1996;54:563–574. doi: 10.1095/biolreprod54.3.563. [DOI] [PubMed] [Google Scholar]
  • 52.Simon C, Mercader A, Gimeno MJ, Pellicer A. The interleukin 1 system and human implantation. Am J Reprod Immunol. 1997;37:64–72. doi: 10.1111/j.1600-0897.1997.tb00193.x. [DOI] [PubMed] [Google Scholar]
  • 53.Paulesu L, Romagnoli R, Bigliardi E. Materno–fetal immunotolerance: is interleukin-1 a fundamental mediator in placental viviparity? Dev Comp Immunol. 2005;29:409–415. doi: 10.1016/j.dci.2004.09.007. [DOI] [PubMed] [Google Scholar]
  • 54.Stewart C, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, et al. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature. 1992;359:76–79. doi: 10.1038/359076a0. [DOI] [PubMed] [Google Scholar]
  • 55.Delage G, Moreau J-F, Taupin J-L, Freitas S, Hambartsoumian E, Olivennes F, et al. In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod. 1995;10:2483–2488. doi: 10.1093/oxfordjournals.humrep.a136328. [DOI] [PubMed] [Google Scholar]
  • 56.Delage G, Moreau J-F, Taupin J-L, Hambartsoumian E, Frydman R, Tartakowsky B, et al. Abnormal endometrial reactivity to colony stimulating factor 1 and leukemia inhibitory factor dependent female infertility. Contracept Fertil Sex. 1997;25:711–716. [PubMed] [Google Scholar]
  • 57.Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, LiI TC, Zhang X. The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod. 1997;12:569–574. doi: 10.1093/humrep/12.3.569. [DOI] [PubMed] [Google Scholar]
  • 58.Hambartsoumian E. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol. 1998;39:137–143. doi: 10.1111/j.1600-0897.1998.tb00345.x. [DOI] [PubMed] [Google Scholar]
  • 59.Hambartsoumian E, Taupin JL, Moreau JF, Frydman R, Chaouat G. In-vivo administration of progesterone inhibits the secretion of endometrial leukaemia inhibitory factor in vitro. Mol Hum Reprod. 1998;4:1039–1044. doi: 10.1093/molehr/4.11.1039. [DOI] [PubMed] [Google Scholar]
  • 60.Song JH, Houde A, Murphy BD. Cloning of leukemia inhibitory factor (LIF) and its expression in the uterus during embryonic diapause and implantation in the mink (Mustela vison) Mol Reprod Dev. 1998;51:13–21. doi: 10.1002/(SICI)1098-2795(199809)51:1<13::AID-MRD2>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  • 61.Basak S, Dubanchet S, Zourbas S, Chaouat G, Das C. Expression of pro-inflammatory cytokines in mouse blastocysts during implantation: modulation by steroid hormones. Am J Reprod Immunol. 2002;47:2–11. doi: 10.1034/j.1600-0897.2002.1o047.x. [DOI] [PubMed] [Google Scholar]
  • 62.Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod. 1999;6:581–586. doi: 10.1093/molehr/5.6.581. [DOI] [PubMed] [Google Scholar]
  • 63.Mikolajczyk M, Wirstlein P, Skrzypczak J. Leukaemia inhibitory factor and interleukin 11 levels in uterine flushings of infertile patients with endometriosis. Hum Reprod. 2006;21(12):3054–3058. doi: 10.1093/humrep/del225. [DOI] [PubMed] [Google Scholar]
  • 64.Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online. 2006;13:13–23. doi: 10.1016/s1472-6483(10)62011-1. [DOI] [PubMed] [Google Scholar]
  • 65.Tartakovsky B, Goldstein O, Brosh N. Colony-stimulating factor-1 blocks early pregnancy in mice. Biol Reprod. 1991;44:906–912. doi: 10.1095/biolreprod44.5.906. [DOI] [PubMed] [Google Scholar]
  • 66.Brosh N, Lotan M, Eisenbach L, Brocke S, Tartakovsky B. Fertility impairment and improved fetal survival induced by a tumor cell line in mice. Am J Reprod Immunol. 1991;26:47–51. doi: 10.1111/j.1600-0897.1991.tb00702.x. [DOI] [PubMed] [Google Scholar]
  • 67.Ledée Bataille N, Lapprée Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod. 2001;10:2073–2078. doi: 10.1093/humrep/17.1.213. [DOI] [PubMed] [Google Scholar]
  • 68.Bilinski P, Roopenian D, Gossler A. Maternal IL-11R alpha function is required for normal decidua and fetoplacental development in mice. Genes Dev. 1998;12:2234–2243. doi: 10.1101/gad.12.14.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Robb L, Li R, Hartley L, Nandurkar H, Koetgen F, Begley CG. Infertility in female mice lacking the receptor for interleukin-11 is due to a defective uterine response to implantation. Nat Med. 1998;4:303–308. doi: 10.1038/nm0398-303. [DOI] [PubMed] [Google Scholar]
  • 70.White CA, Robb L, Salamonsen LA. Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor α deficient mice. Reprod Biol Endocrinol. 2004;10:76. doi: 10.1186/1477-7827-2-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Linjawi S, Li TC, Tuckerman EM, Blakemore AI, Laird SM. Expression of interleukin-11 receptor alpha and interleukin-11 protein in the endometrium of normal fertile women and women with recurrent miscarriage. J Reprod Immunol. 2004;64:145–155. doi: 10.1016/j.jri.2004.08.007. [DOI] [PubMed] [Google Scholar]
  • 72.White CA, Dimitriadis E, Sharkey AM, Stoikos CJ, Salamonsen LA. Interleukin 1 β is induced by interleukin 11 during decidualization of human endometrial stromal cells, but is not released in a bioactive form. J Reprod Immunol. 2007;73:28–38. doi: 10.1016/j.jri.2006.05.003. [DOI] [PubMed] [Google Scholar]
  • 73.Dimitriadis E, Stoikos C, Tan YL, Salamonsen LA. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. Endocrinology. 2006;147:3809–3817. doi: 10.1210/en.2006-0264. [DOI] [PubMed] [Google Scholar]
  • 74.Ain R, Trinh ML, Soares MJ. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal–fetal interface. Dev Dyn. 2004;231:700–708. doi: 10.1002/dvdy.20183. [DOI] [PubMed] [Google Scholar]
  • 75.Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online. 2006;13:13–23. doi: 10.1016/s1472-6483(10)62011-1. [DOI] [PubMed] [Google Scholar]
  • 76.Dimitriadis E, Stoikos C, Stafford-Bell M, Clark I, Paiva P, Kovacs G, et al. Interleukin-11, IL-11 receptor alpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol. 2006;69:53–64. doi: 10.1016/j.jri.2005.07.004. [DOI] [PubMed] [Google Scholar]
  • 77.Mikolajczyk M, Wirstlein P, Skrzypczak J. Leukaemia inhibitory factor and interleukin 11 levels in uterine flushings of infertile patients with endometriosis. Hum Reprod. 2006;21:3054–3058. doi: 10.1093/humrep/del225. [DOI] [PubMed] [Google Scholar]
  • 78.Ledee-Bataille N, Dubanchet S, Kadoch J, Castelo-Branco A, Frydman R, Chaouat G. Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count. Fertil Steril. 2004;82:234–236. doi: 10.1016/j.fertnstert.2003.12.030. [DOI] [PubMed] [Google Scholar]
  • 79.Makkar G, Ng EH, Yeung WS, Ho PC. Reduced expression of interleukin-11 and interleukin-6 in the periimplantation endometrium of excessive ovarian responders during in vitro fertilization treatment. J Clin Endocrinol Metab. 2006;91:3181–3188. doi: 10.1210/jc.2006-0180. [DOI] [PubMed] [Google Scholar]
  • 80.Zourbas S, Dubanchet S, Martal J, Chaouat G. Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the feto maternal interface during murine pregnancy. Clin Exp Immunol. 2001;126:519–528. doi: 10.1046/j.1365-2249.2001.01607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Verma S, Hiby SE, Loke YW, King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod. 2000;62:959–968. doi: 10.1095/biolreprod62.4.959. [DOI] [PubMed] [Google Scholar]
  • 82.Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol. 2003;171:2937–2944. doi: 10.4049/jimmunol.171.6.2937. [DOI] [PubMed] [Google Scholar]
  • 83.Laskarin G, Strbo N, Bogovic Crncic T, Juretic K, Ledee Bataille N, Chaouat G, et al. Physiological role of IL-15 and IL-18 at the maternal–fetal interface. Chem Immunol Allergy. 2005;9:10–25. doi: 10.1159/000087906. [DOI] [PubMed] [Google Scholar]
  • 84.Barber EM, Pollard JW. The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J Immunol. 2003;71:37–46. doi: 10.4049/jimmunol.171.1.37. [DOI] [PubMed] [Google Scholar]
  • 85.Chegini N, Ma C, Roberts M, Williams RS, Ripps BA. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol. 2002;56:93–110. doi: 10.1016/s0165-0378(02)00043-8. [DOI] [PubMed] [Google Scholar]
  • 86.Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod. 2007;13:123–133. doi: 10.1093/molehr/gal100. [DOI] [PubMed] [Google Scholar]
  • 87.Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994;13:1189–1196. doi: 10.1002/j.1460-2075.1994.tb06368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Robertson SA, et al. The effect of interleukin-6 deficiency on implantation, fetal development and parturition in mice. Proc Aust Soc Reprod Biol. 2000;31:97. [Google Scholar]
  • 89.Zenclussen AC, Blois S, Stumpo R, Olmos S, Arias K, Malan Borel I, et al. Murine abortion is associated with enhanced interleukin-6 levels at the feto–maternal interface. Cytokine. 2003;24:150–160. doi: 10.1016/j.cyto.2003.08.002. [DOI] [PubMed] [Google Scholar]
  • 90.Robertson SA, Mau VJ, Young IG, Matthaei KI. Uterine eosinophils and reproductive performance in interleukin 5-deficient mice. J Reprod Fertil. 2000;120:423–432. doi: 10.1530/jrf.0.1200423. [DOI] [PubMed] [Google Scholar]
  • 91.Herrler A, Rango U, Beier HM. Embryo–maternal signalling: how the embryo starts talking to its mother to accomplish implantation. Reprod Biomed Online. 2003;6:244–256. doi: 10.1016/S1472-6483(10)61717-8. [DOI] [PubMed] [Google Scholar]
  • 92.Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Updat. 2005;11:613–630. doi: 10.1093/humupd/dmi023. [DOI] [PubMed] [Google Scholar]
  • 93.Chen S, Cao Y, Zeng G, Duan E. Transforming growth factor-α promotes mouse blastocyst outgrowth and secretion of matrix metalloproteinases. Chin Med J. 2001;114:1300–1304. [PubMed] [Google Scholar]
  • 94.Kim JH, Hong SH, Nah HY, Lee JY, Chae HD, Kim CH, et al. Influence of transforming growth factor-α on expression of matrix metalloproteinase-2, matrix metalloproteinase-9, and epidermal growth factor receptor gene in the mouse blastocysts. J Assist Reprod Genet. 2002;19:232–239. doi: 10.1023/A:1015310919415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Nowak RA, Haimovici F, Biggers JD, Erbach GT. Transforming growth factor-β stimulates mouse blastocyst outgrowth through a mechanism involving parathyroid hormone-related protein. Biol Reprod. 1999;60:85–93. doi: 10.1095/biolreprod60.1.85. [DOI] [PubMed] [Google Scholar]
  • 96.Idris N, Carraway KL. Regulation of sialomucin complex/Muc4 expression in rat uterine luminal epithelial cells by transforming growth factor-beta: implications for blastocyst implantation. J Cell Physiol. 2000;185:310–316. doi: 10.1002/1097-4652(200011)185:2<310::AID-JCP16>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  • 97.Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770–774. doi: 10.1073/pnas.90.2.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Das SK, Lim H, Wang J, Paria BC, BazDresch M, Dey SK. Inappropriate expression of human transforming growth factor (TGF)-α in the uterus of transgenic mouse causes downregulation of TGF-β receptors and delays the blastocyst-attachment reaction. J Mol Endocrinol. 1997;18:243–257. doi: 10.1677/jme.0.0180243. [DOI] [PubMed] [Google Scholar]
  • 99.Clark DA, Flanders KC, Banwatt D, Millar-Book W, Manuel J, Stedronska-Clark J, et al. Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor β-2. J Immunol. 1990;144:3008–3014. [PubMed] [Google Scholar]
  • 100.Clark DA, Coker R. Transforming growth factor-beta (TGF-β) Int J Biochem Cell Biol. 1998;30:293–298. doi: 10.1016/s1357-2725(97)00128-3. [DOI] [PubMed] [Google Scholar]
  • 101.Gorczynski RM, Hadidi S, Yu G, Clark DA. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol. 2002;48:18–26. doi: 10.1034/j.1600-0897.2002.01094.x. [DOI] [PubMed] [Google Scholar]
  • 102.Mohamed OA, Jonnaert M, Labelle-Dumais C, Kuroda K, Clarke HJ, Dufort D. Uterine Wnt/β-catenin signaling is required for implantation. Proc Natl Acad Sci USA. 2005;102:8579–8584. doi: 10.1073/pnas.0500612102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Th1/Th2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol. 2004;134:93–119. doi: 10.1159/000074300. [DOI] [PubMed] [Google Scholar]
  • 104.Entrican G. Immune regulation during pregnancy and host–pathogen interactions in infectious abortion. J Comp Pathol. 2002;126:79–94. doi: 10.1053/jcpa.2001.0539. [DOI] [PubMed] [Google Scholar]
  • 105.Soto P, Natzke RP, Hansen PJ. Actions of tumor necrosis factor-α on oocyte maturation and embryonic development in cattle. Am J Reprod Immunol. 2003;50:380–388. doi: 10.1034/j.1600-0897.2003.00101.x. [DOI] [PubMed] [Google Scholar]
  • 106.Meirom R, Moss S, Bernstein M, Bider Z, Brenner J. The association between tumour necrosis factor-α, interleukin-6 and microbiological findings in the synovial fluid of aborted and neonatal calves. Zentralbl Veterinarmed B. 1996;43:439–444. doi: 10.1111/j.1439-0450.1996.tb00336.x. [DOI] [PubMed] [Google Scholar]
  • 107.Talwar GP, Shah S, Mukherjee S, Chabra R. Induced termination of pregnancy by purified extracts of Azadirachta Indica (Neem): mechanisms involved. Am J Reprod Immunol. 1997;37:485–491. doi: 10.1111/j.1600-0897.1997.tb00264.x. [DOI] [PubMed] [Google Scholar]
  • 108.Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumour necrosis factor-α, interleukin-1α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases. Mol Hum Reprod. 1999;5:252–260. doi: 10.1093/molehr/5.3.252. [DOI] [PubMed] [Google Scholar]
  • 109.Cohen M, Meisser A, Haenggeli L, Bischof P. Involvement of MAPK pathway in TNF-α-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod. 2006;12:225–232. doi: 10.1093/molehr/gal023. [DOI] [PubMed] [Google Scholar]
  • 110.Mas AE, Dubanchet S, Fay S, Ledée N, Chaouat G. Immune regulation at the interface during early steps of murine implantation: involvement of new IL-12 family cytokines (IL-23 and IL-27) and TWEAK. Presentation at the Banff JRI/Elsevier conference on reproductive immunology. Banff. November 15–18, 2006.
  • 111.Bell E. TWEAK and TNF: Yin and Yang in innate immunity. Research highlights in nature reviews. Immunology. 2006;6:91–99. [Google Scholar]
  • 112.Toder V, Fein A, Carp H, Torchinsky A. TNF-α in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet. 2003;20:73–81. doi: 10.1023/A:1021740108284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot J, Mossmann T, et al. IL-10 prevents inflammatory cytokine-mediated fetal death and is inducible by tau interferon. J Immunol. 1995;152:2411–2420. [Google Scholar]
  • 114.Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol. 2001;51:3–7. doi: 10.1016/s0165-0378(01)00065-1. [DOI] [PubMed] [Google Scholar]
  • 115.Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R, et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity. 2002;17:7–17. doi: 10.1016/s1074-7613(02)00332-1. [DOI] [PubMed] [Google Scholar]
  • 116.White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod. 2004;70:123–131. doi: 10.1095/biolreprod.103.018754. [DOI] [PubMed] [Google Scholar]
  • 117.Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol. 2006;177:4888–4896. doi: 10.4049/jimmunol.177.7.4888. [DOI] [PubMed] [Google Scholar]
  • 118.Vince GS, Johnson PM. Is there a Th2 bias in human pregnancy? J Reprod Immunol. 1996;32:101–104. doi: 10.1016/s0165-0378(96)00995-3. [DOI] [PubMed] [Google Scholar]
  • 119.Robertson SA. Seminal fluid signaling in the female reproductive tract: lessons from rodents and pigs. J Anim Sci. 2006;85(13 Suppl):E36–44. doi: 10.2527/jas.2006-578. [DOI] [PubMed] [Google Scholar]
  • 120.Robertson SA, O’Leary S, Armstrong DT. Influence of semen on inflammatory modulators of embryo implantation. Soc Reprod Fertil Suppl. 2006;62:231–245. [PubMed] [Google Scholar]
  • 121.Baines MG, Gendron RL. Natural and experimental animal models of reproductive failure. In: Chaouat G, editor. Immunology of pregnancy. Boca Raton: CRC; 1993. pp. 173–203. [Google Scholar]
  • 122.Loke YW, King A. Recent developments in the human maternal–fetal immune interaction. Curr Opin Immunol. 1991;5:762–766. doi: 10.1016/0952-7915(91)90110-m. [DOI] [PubMed] [Google Scholar]
  • 123.Bulmer JN, Hagin SV, Browne CM, Billington WD. Localization of immunoglobulin-containing cells in human endometrium in the first trimester of pregnancy and throughout the menstrual cycle. Eur J Obstet Gynecol Reprod Biol. 1986;23:31–44. doi: 10.1016/0028-2243(86)90102-4. [DOI] [PubMed] [Google Scholar]
  • 124.Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod. 1991;6:791–798. doi: 10.1093/oxfordjournals.humrep.a137430. [DOI] [PubMed] [Google Scholar]
  • 125.Parr EL, Young LH, Parr MB, Young JD. Granulated metrial gland cells of pregnant mouse uterus are natural killer-like cells that contain perforin and serine esterases. J Immunol. 1990;145:2365–2372. [PubMed] [Google Scholar]
  • 126.Kiso Y, McBey BA, Mason L, Croy BA. Histological assessment of the mouse uterus from birth to puberty for the appearance of LGL-1+ natural killer cells. Biol Reprod. 1992;47:227–232. doi: 10.1095/biolreprod47.2.227. [DOI] [PubMed] [Google Scholar]
  • 127.Linnemeyer PA, Pollack SB. Murine granulated metrial gland cells at uterine implantation sites are natural killer lineage cells. J Immunol. 1991;147:2530–2535. [PubMed] [Google Scholar]
  • 128.Croy BA, Ashkar AA, Foster RA, DiSanto JP, Magram J, Carson D, et al. Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol. 1997;35:111–133. doi: 10.1016/s0165-0378(97)00054-5. [DOI] [PubMed] [Google Scholar]
  • 129.Ostojic S, Dubanchet S, Mjihdi A, Truyens C, Capron F, Chaouat G. Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol. 2003;49:101–113. doi: 10.1034/j.1600-0897.2003.01150.x. [DOI] [PubMed] [Google Scholar]
  • 130.Hayakawa S, Fujikawa T, Fukuoka H, Chisima F, Karasaki-Suzuki M, Ohkoshi E, et al. Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation. J Reprod Immunol. 2000;47:121–138. doi: 10.1016/s0165-0378(00)00053-x. [DOI] [PubMed] [Google Scholar]
  • 131.Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficiency (SCID) mice reverses the reproductive deficit in Natural Killer cells deficient TgE26 mice. J Exp Med. 1998;187:217–223. doi: 10.1084/jem.187.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Ashkar AA, Croy BA. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol. 2001;13:235–241. doi: 10.1006/smim.2000.0319. [DOI] [PubMed] [Google Scholar]
  • 133.Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med. 2000;192:259–270. doi: 10.1084/jem.192.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol. 2003;171:2937–2944. doi: 10.4049/jimmunol.171.6.2937. [DOI] [PubMed] [Google Scholar]
  • 135.Monk JM, Leonard S, Mc Bey BA, Croy BA. Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta. 2005;10:835–838. doi: 10.1016/j.placenta.2004.10.016. [DOI] [PubMed] [Google Scholar]
  • 136.Leonard S, Murrant C, Tayade C, Heuvel M, Watering R, Croy BA. Mechanisms regulating immune cell contributions to spiral artery modification —facts and hypotheses—a review. Placenta. 2006;Suppl A:S40–46. doi: 10.1016/j.placenta.2005.11.007. [DOI] [PubMed] [Google Scholar]
  • 137.Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of pre eclampsia? J Soc Gynecol Investig. 2001;7:12–20. doi: 10.1016/s1071-5576(99)00049-0. [DOI] [PubMed] [Google Scholar]
  • 138.Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab. 2000;86:1823–1834. doi: 10.1210/jcem.86.4.7418. [DOI] [PubMed] [Google Scholar]
  • 139.Wang C, Tanaka T, Nakamura H, Umesaki N, Hirai K, Ishiko O, et al. Granulated metrial gland cells in the murine uterus: localization, kinetics, and the functional role in angiogenesis during pregnancy. Microsc Res Tech. 2003;60:420. doi: 10.1002/jemt.10280. [DOI] [PubMed] [Google Scholar]
  • 140.Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80:572–580. doi: 10.1189/jlb.0406250. [DOI] [PubMed] [Google Scholar]
  • 141.Xie X, He H, Colonna M, Seya T, Takai T, Croy BA. Pathways participating in activation of mouse uterine natural killer cells during pregnancy. Biol Reprod. 2005;73(3):510–518. doi: 10.1095/biolreprod.104.033951. [DOI] [PubMed] [Google Scholar]
  • 142.Anderson DJ, Hill JA. Cell mediated immunity in infertility. Am J Reprod Immunol. 1992;17:22–31. doi: 10.1111/j.1600-0897.1988.tb00197.x. [DOI] [PubMed] [Google Scholar]
  • 143.Hill JA. T helper 1 immunity to trophoblast: Evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod. 1995;10:114–120. doi: 10.1093/humrep/10.suppl_2.114. [DOI] [PubMed] [Google Scholar]
  • 144.Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA. 1995;273:1933–1936. [PubMed] [Google Scholar]
  • 145.Albieri A, Hoshida MS, Gagioti SM, Leanza EC, Abrahamsohn I, Croy A, et al. Interferon-γ alters the phagocytic activity of the mouse trophoblast. Reprod Biol Endocrinol. 2005;3:34. doi: 10.1186/1477-7827-3-34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Smith SK. Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab. 2001;1:147–151. doi: 10.1016/s1043-2760(01)00379-4. [DOI] [PubMed] [Google Scholar]
  • 147.Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the female reproductive organs: pathological implications. Int J Exp Pathol. 2002;83:151–163. doi: 10.1046/j.1365-2613.2002.00277.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Krussel JS, Bielfeld P, Polan ML, Simon C. Regulation of embryonic implantation. Eur J Obstet Gynecol Reprod Biol. 2003;110(Suppl 1):S2–9. doi: 10.1016/s0301-2115(03)00167-2. [DOI] [PubMed] [Google Scholar]
  • 149.Das SK, Chakraborty I, Wang J, Dey SK, Hoffman LH. Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. Biol Reprod. 1997;56:1390–1399. doi: 10.1095/biolreprod56.6.1390. [DOI] [PubMed] [Google Scholar]
  • 150.Yi XJ, Jiang HY, Lee KK, O WS, Tang PL, Chow PH. Expression of vascular endothelial growth factor (VEGF) and its receptors during embryonic implantation in the golden hamster (Mesocricetus auratus) Cell Tissue Res. 1999;296:339–349. doi: 10.1007/s004410051294. [DOI] [PubMed] [Google Scholar]
  • 151.Albrecht ED, Aberdeen GW, Niklaus AL, Babischkin JS, Suresch DL, Pepe GJ. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocrinol Metab. 2003;88:2844–2852. doi: 10.1210/jc.2002-021546. [DOI] [PubMed] [Google Scholar]
  • 152.Lopes FL, Desmarais J, Gevry NY, Ledoux S, Murphy BD. Expression of vascular endothelial growth factor isoforms and receptors Flt-1 and KDR during the peri-implantation period in the mink, Mustela vison. Biol Reprod. 2003;68:1926–1933. doi: 10.1095/biolreprod.102.013441. [DOI] [PubMed] [Google Scholar]
  • 153.Pfarrer CD, Ruziwa SD, Winther H, Callesen H, Leiser R, Schams D, et al. Localization of vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in bovine placentomes from implantation until term. Placenta. 2006;8:889–898. doi: 10.1016/j.placenta.2005.09.004. [DOI] [PubMed] [Google Scholar]
  • 154.Niklaus AL, Babischkin JS, Aberdeen GW, Pepe GJ, Albrecht ED. Expression of vascular endothelial growth/permeability factor by endometrial glandular epithelial and stromal cells in baboons during the menstrual cycle and after ovariectomy. Endocrinology. 2002;143:4007–4017. doi: 10.1210/en.2002-220385. [DOI] [PubMed] [Google Scholar]
  • 155.Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis. 1998;2:167–182. doi: 10.1023/a:1009292506879. [DOI] [PubMed] [Google Scholar]
  • 156.Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, et al. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod. 2006;6:367–375. doi: 10.1093/molehr/gal027. [DOI] [PubMed] [Google Scholar]
  • 157.Berndt S, Perrier d’Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006;14:2630–2632. doi: 10.1096/fj.06-5885fje. [DOI] [PubMed] [Google Scholar]
  • 158.Narvekar N, Critchley HO, Cheng L, Baird DT. Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor. Hum Reprod. 2006;9:2312–2318. doi: 10.1093/humrep/del182. [DOI] [PubMed] [Google Scholar]
  • 159.Loke YW, King A. Human implantation. Cell Biology and Immunology. Cambridge University Press; 1995.
  • 160.Bouteiller P, Blaschitz A. The functionality of HLA-G is emerging. Immunol Rev. 1999;167:233–244. doi: 10.1111/j.1600-065x.1999.tb01396.x. [DOI] [PubMed] [Google Scholar]
  • 161.Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Bouteiller P, et al. Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol. 2006;56:275–285. doi: 10.1111/j.1600-0897.2006.00420.x. [DOI] [PubMed] [Google Scholar]
  • 162.Meer A, Lukassen HG, Lierop MJ, Wijnands F, Mosselman S, Braat DD, et al. Membrane-bound HLA-G activates proliferation and interferon-γ production by uterine natural killer cells. Mol Hum Reprod. 2004;3:189–195. doi: 10.1093/molehr/gah032. [DOI] [PubMed] [Google Scholar]
  • 163.Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med. 2006;12:991–992. doi: 10.1038/nm0906-991. [DOI] [PubMed] [Google Scholar]
  • 164.Sharkey AM, Catalano R, Evans A, Charnock-Jones DS, Smith SK. Novel antiangiogenic agents for use in contraception. Contraception. 2005;71:263–271. doi: 10.1016/j.contraception.2004.12.018. [DOI] [PubMed] [Google Scholar]
  • 165.Smith SK. Angiogenesis and implantation. Hum Reprod. 2000;Suppl 6:59–66. [PubMed] [Google Scholar]
  • 166.Hess AP, Hirchenhain J, Schanz A, Talbi S, Hamilton AE, Giudice LC, et al. Angiopoietin-1 and -2 mRNA and protein expression in mouse preimplantation embryos and uteri suggests a role in angiogenesis during implantation. Reprod Fertil Dev. 2006;18:509–516. doi: 10.1071/rd05110. [DOI] [PubMed] [Google Scholar]
  • 167.Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol. 2001;52:35–43. doi: 10.1016/s0165-0378(01)00111-5. [DOI] [PubMed] [Google Scholar]
  • 168.Piccinni MP. T cell cytokines in pregnancy. Am J Reprod Immunol. 2002;47:289–294. doi: 10.1034/j.1600-0897.2002.01104.x. [DOI] [PubMed] [Google Scholar]
  • 169.Piccinni MP. Tcells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed Online. 2006;6:840–844. doi: 10.1016/s1472-6483(10)61033-4. [DOI] [PubMed] [Google Scholar]
  • 170.Gorivodsky M, Torchinsky A, Shepshelovich J, Savion S, Fein A, Carp H, et al. Colony-stimulating factor-1 (CSF-1) expression in the uteroplacental unit of mice with spontaneous and induced pregnancy loss. Clin Exp Immunol. 1999;7:540–549. doi: 10.1046/j.1365-2249.1999.00986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Zenclussen AC, Fest S, Joachim R, Busse P, Klapp BF, Arck PC. Introducing a novel mouse model for preeclampsia. Am J Reprod Immunol. 2002;47:353. [Google Scholar]
  • 172.Schmid M, Sollwedel A, Thuere C, Wafula PO, Zenclussen ML, Muller DN, et al. Murine pre-eclampsia induced by unspecific activation of the immune system correlates with alterations in the eNOS and AT1 receptor expression in the kidneys and placenta. Placenta 2006; Nov 25 (in press). [DOI] [PubMed]
  • 173.Ledee-Bataille N, Olivennes F, Kadoch J, Dubanchet S, Frydman N, Chaouat G, et al. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Hum Reprod. 2004;9:1968–1973. doi: 10.1093/humrep/deh356. [DOI] [PubMed] [Google Scholar]
  • 174.Brosh N, Lotan M, Eisenbach L, Brocke S, Tartakovsky B. Fertility impairment and improved fetal survival induced by a tumor cell line in mice. Am J Reprod Immunol. 1991;1:47–51. doi: 10.1111/j.1600-0897.1991.tb00702.x. [DOI] [PubMed] [Google Scholar]
  • 175.Tartakovsky B, Goldstein O, Brosh N. Colony-stimulating factor-1 blocks early pregnancy in mice. Biol Reprod. 1991;44:906–912. doi: 10.1095/biolreprod44.5.906. [DOI] [PubMed] [Google Scholar]
  • 176.Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine dependent abortion in CBA × DBA/2 mice is mediated by the procooagulant fgl/2 prothrombinase. J Immunol. 1998;160:550–555. [PubMed] [Google Scholar]
  • 177.Knackstedt MK, Hamelmann E, Arck PC. Mothers in stress: consequences for the offspring. Am J Reprod Immunol. 2005;54:63–69. doi: 10.1111/j.1600-0897.2005.00288.x. [DOI] [PubMed] [Google Scholar]
  • 178.Tometten M, Blois S, Arck PC. Nerve growth factor in reproductive biology: link between the immune, endocrine and nervous system? Chem Immunol Allergy. 2005;89:135–148. doi: 10.1159/000087962. [DOI] [PubMed] [Google Scholar]
  • 179.Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol. 2003;49:297–307. doi: 10.1034/j.1600-0897.2003.00045.x. [DOI] [PubMed] [Google Scholar]
  • 180.Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am J Reprod Immunol. 2005;54:203–216. doi: 10.1111/j.1600-0897.2005.00299.x. [DOI] [PubMed] [Google Scholar]
  • 181.Wiekowski M, Leach M, Evans E. Ubiquitinous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J Immunol. 2001;166:7563–7570. doi: 10.4049/jimmunol.166.12.7563. [DOI] [PubMed] [Google Scholar]
  • 182.Paradisi R, Maldini-Casadei M, Boni P, Busacchi P, Porcu E, Venturoli S. T-helper 2-cytokine levels in women with threatened abortion. Eur J Obstet Gynecol Reprod Biol. 2003;111:43–49. doi: 10.1016/s0301-2115(03)00119-2. [DOI] [PubMed] [Google Scholar]
  • 183.Hossein H, Mahroo M, Abbas A, Firouzeh A, Nadia H. Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine. 2004;28:83–86. doi: 10.1016/j.cyto.2004.07.002. [DOI] [PubMed] [Google Scholar]
  • 184.Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. 1999;196:122–130. doi: 10.1006/cimm.1999.1532. [DOI] [PubMed] [Google Scholar]
  • 185.Lea RG, Unedrwood J, Flanders KC, Hirte H, Banwatt D, Finotto S, et al. A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor β-2-producing “suppressor cells” near the placental attachment site. Am J Reprod Immunol. 1995;34:52–64. doi: 10.1111/j.1600-0897.1995.tb00919.x. [DOI] [PubMed] [Google Scholar]
  • 186.Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest. 1999;103:1641–1650. doi: 10.1172/JCI6380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266–271. doi: 10.1038/ni1037. [DOI] [PubMed] [Google Scholar]
  • 188.Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol Rev. 2006;212:330–343. doi: 10.1111/j.0105-2896.2006.00408.x. [DOI] [PubMed] [Google Scholar]
  • 189.Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112:38–43. doi: 10.1111/j.1365-2567.2004.01869.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190.Saito S, Sasaki Y, Sakai M. CD4 (+) CD25 high regulatory T cells in human pregnancy. J Reprod Immunol. 2005;65:111–120. doi: 10.1016/j.jri.2005.01.004. [DOI] [PubMed] [Google Scholar]
  • 191.Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod. 2006;12:301–308. doi: 10.1093/molehr/gal032. [DOI] [PubMed] [Google Scholar]
  • 192.Bischof P, Campana A. Molecular mediators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:801–814. doi: 10.1053/beog.2000.0120. [DOI] [PubMed] [Google Scholar]
  • 193.Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR, Schultz GA. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development. 1995;4:1005–1014. doi: 10.1242/dev.121.4.1005. [DOI] [PubMed] [Google Scholar]
  • 194.Karmakar S, Dhar R, Das C. Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon γ-mediated pathway. J Biol Chem. 2004;279:55297–55307. doi: 10.1074/jbc.M407013200. [DOI] [PubMed] [Google Scholar]
  • 195.Karmakar S, Das C. Regulation of trophoblast invasion by IL-1beta and TGF-β1. Am J Reprod Immunol. 2002;48:210–219. doi: 10.1034/j.1600-0897.2002.01151.x. [DOI] [PubMed] [Google Scholar]
  • 196.Lessey BA. Adhesion molecules and implantation. J Reprod Immunol. 2002;55:101–112. doi: 10.1016/s0165-0378(01)00139-5. [DOI] [PubMed] [Google Scholar]
  • 197.Minas V, Loutradis D, Makrigiannakis A. Factors controlling blastocyst implantation. Reprod Biomed Online. 2005;10:205–216. doi: 10.1016/s1472-6483(10)60942-x. [DOI] [PubMed] [Google Scholar]
  • 198.Das C, Basak S. Expression and regulation of integrin receptors in human trophoblast cells: role of estradiol and cytokines. Indian J Exp Biol. 2003;41:748–755. [PubMed] [Google Scholar]
  • 199.Johnson GA, Burghardt RC, Bazer FW, Spencer TE. Osteopontin: roles in implantation and placentation. Biol Reprod. 2003;69:1458–1471. doi: 10.1095/biolreprod.103.020651. [DOI] [PubMed] [Google Scholar]
  • 200.Ramos MP, Rueda BR, Leavis PC, Gonzalez RR. Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process. Endocrinology. 2005;146:694–701. doi: 10.1210/en.2004-1186. [DOI] [PubMed] [Google Scholar]
  • 201.Tartakowky B, Goldstein O, Ben Yair B. In vivo modulation of pre embryonic development by cytokines. In Biologie Cellulaire et Moléculaire de la Relation Materno Fetale. Editions INSERM John Libbey; 1991. pp. 239–245.
  • 202.Tartakovsky B, Ben-Yair E. Cytokines modulate preimplantation development and pregnancy. Dev Biol. 1991;146:345–352. doi: 10.1016/0012-1606(91)90236-v. [DOI] [PubMed] [Google Scholar]
  • 203.Paldi A. Genomic imprinting and feto maternal relationship. In Biologie Cellulaire et Moléculaire de la Relation Materno Fetale. Colloque INSERM 254. Editions INSERM John Libbey; 1991. pp. 61–66.
  • 204.Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203:2165–2175. doi: 10.1084/jem.20061022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205.Munn DH, Zhou M, Atwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–1193. doi: 10.1126/science.281.5380.1191. [DOI] [PubMed] [Google Scholar]
  • 206.Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol Rev. 2006;212:330–343. doi: 10.1111/j.0105-2896.2006.00408.x. [DOI] [PubMed] [Google Scholar]
  • 207.Humblet-Baron S, Sather B, Becker-Herman S, Kasprowicz DJ, Khim S, Nguyen T, et al. Wiskott–Aldrich syndrome protein is required for T cell homeostasis. J Clin Invest. 2007;117:407–418. doi: 10.1172/JCI29539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208.Marangoni F, Trifari S, Scaramuzza S, Panaronu C, Martino S, Notaragelo LD, et al. WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells. J Exp Med. 2007;204:369–380. doi: 10.1084/jem.20061334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, et al. The Wiskott–Aldrich syndrome protein is required for the function of CD4+CD25+FOXP3+ regulatory T cells. J Exp Med. 2007;204:381–391. doi: 10.1084/jem.20061338. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES